Isolation and functional use of human NKT cells

Current Protocols in Immunology

Volumn , Issue SUPPL. 90, 2010, Pages

  Exley, Mark A ^a   Wilson, Brian ^b   Balk, Steven P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

galactosylceramide; CD1d; human; invariant T cell receptor; NKT cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD161 ANTIGEN; CD1D ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6B11; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

CELL ASSAY; CELL EXPANSION; CELL ISOLATION; CELL SELECTION; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOLYSIS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; LYMPHOCYTE FUNCTION; LYMPHOID CELL LINE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SEPARATION; CLONE CELLS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; MICE; NATURAL KILLER T-CELLS;

MURINAE;

EID: 77956492375     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1411s90     Document Type: Review

References (41)

1. Behar, S.M., Podrebarac, T.A., Roy, C.J., Wang, C.R., and, Brenner, M.B., 1999. Diverse TCRs recognize murine CD1. J. Immunol. 162: 161 - 167.
2. Bendelac, A., Savage, P.B., and, Teyton, L., 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297 - 336.
3. Bricard, G., Cesson, V., Devevre, E., Bouzourene, H., Barbey, C., Rufer, N., Im, J.S., Alves, P.M., Martinet, O., Halkic, N., Cerottini, J.C., Romero, P., Porcelli, S.A., Macdonald, H.R., and, Speiser, D.E., 2009. Enrichment of human CD4 V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. J. Immunol. 182: 5140 - 5151.
4. Brigl, M., and, Brenner, M.B., 2004. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817 - 890.
5. Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E., and, Brenner, M.B., 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230 - 1237.
6. Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P., and, Kronenberg, M., 1998. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188: 1521 - 1528.
7. Chiu, Y.H., Jayawardena, J., Weiss, A., Lee, D., Park, S.H., Dautry-Varsat, A., and, Bendelac, A., 1999. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189: 103 - 110.
8. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., and, Taniguchi, M., 1997. Requirement for Vαlpha 14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623 - 1626.
9. Dhodapkar, M.V., Geller, M.D., Chang, D.H., Shimizu, K., Fujii, S., Dhodapkar, K.M., and, Krasovsky, J., 2003. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J. Exp. Med. 7: 1667 - 1676.
10. Durante-Mangoni, E., Wang, R., Shaulov, A., He, Q., Nasser, I., Afdhal, N., Koziel, M.J., and, Exley, M.A., 2004. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J. Immunol. 173: 2159 - 2166.
11. Exley, M.A., Garcia, J., Balk, S.P., and, Porcelli, S., 1997. Requirements for CD1d recognition by human invariant Valpha24 CD4-CD8- T cells. J. Exp. Med. 186: 109 - 120.
12. Exley, M.A., Tahir, S.M., Cheng, O., Shaulov, A., Joyce, R., Avigan, D., Sackstein, R., and, Balk, S.P., 2001. A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J. Immunol. 167: 5531 - 5534.
13. Exley, M.A., He, Q., Cheng, O., Wang, R.J., Cheney, C.P., Balk, S.P., and, Koziel, M.J., 2002. Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 168: 1519 - 1523.
14. Exley, M.A., Hou, R., Shaulov, A., Tonti, E., Dellabona, P., Casorati, G., Akbari, O., Akman, H.O., Greenfield, E.A., Gumperz, J.E., Boyson, J.E., Balk, S.P., and, Wilson, S.B., 2008. Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop. Eur. J. Immunol. 38: 1756 - 1766.
15. Fujii, S., Shimizu, K., Steinman, R.M., and, Dhodapkar, M.V., 2003. Detection and activation of human Valpha24 natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells. J. Immunol. Methods 272: 147 - 159.
16. Gadola, S.D., Dulphy, N., Salio, M., and, Cerundolo, V., 2002. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4() and CD8alphabeta() T lymphocytes. J. Immunol. 168: 5514 - 5520.
17. Gansuvd, B., Hubbard, W.J., Hutchings, A., Thomas, F.T., Goodwin, J., Wilson, S.B., Exley, M.A., and, Thomas, J.M., 2003. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells. J. Immunol. 171: 2904 - 2911.
18. Gumperz, J.E., 2004. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: The best of both worlds. Immunol. Cell Biol. 82: 285 - 294.
19. Gumperz, J.E., Miyake, S., Yamamura, T., and, Brenner, M.B., 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625 - 636.
20. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H., and, Taniguchi, M., 1997. CD1d-restricted and TCR-mediated activation of V alpha 14 NKT cells by glycosylceramides. Science 278: 1626 - 1629.
21. Kenna, T., Golden-Mason, L., Porcelli, S.A., Koezuka, Y., Hegarty, J.E., OFarrelly, C., and, Doherty, D.G., 2003. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J. Immunol. 171: 1775 - 1779.
22. Kim, C.H., Butcher, E.C., and, Johnston, B., 2002. Distinct subsets of human Valpha24-invariant NKT cells: Cytokine responses and chemokine receptor expression. Trends Immunol. 23: 516 - 519.
23. Kronenberg, M., and, Kinjo, Y., 2009. Innate-like recognition of microbes by invariant natural killer T cells. Curr. Opin. Immunol. 21: 391 - 396.
24. Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., Porcelli, S., and, Maclaren, N., 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109: 131 - 140.
25. Lee, P.T., Benlagha, K., Teyton, L., and, Bendelac, A., 2002. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195: 637 - 641.
26. Mattner, J., Savage, P.B., Leung, P., Oertelt, S.S., Wang, V., Trivedi, O., Scanlon, S.T., Pendem, K., Teyton, L., Hart, J., Ridgway, W.M., Wicker, L.S., Gershwin, M.E., and, Bendelac, A., 2008. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe. 3: 304 - 315.
27. Metelitsa, L.S., 2004. Flow cytometry for natural killer T cells: Multi-parameter methods for multifunctional cells. Clin. Immunol. 110: 267 - 276.
28. Metelitsa, L.S., Naidenko, O.V., Kant, A., Wu, H.W., Loza, M.J., Perussia, B., Kronenberg, M., and, Seeger, R.C, 2001. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167: 3114 - 3122.
29. Metelitsa, L.S., Wu, H.W., Wang, H., Yang, Y., Warsi, Z., Asgharzadeh, S., Groshen, S., Wilson, S.B., and, Seeger, R.C, 2004. Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J. Exp. Med. 199: 1213 - 1221.
30. Molling, J.W., Kolgen, W., van der Vliet, H.J., Boomsma, M.F., Kruizenga, H., Smorenburg, C.H., Molenkamp, B.G., Langendijk, J.A., Leemans, C.R., von Blomberg, B.M., Scheper, R.J., and, van den Eertwegh, A.J., 2005. Peripheral blood IFN-gamma-secreting Valpha24Vbeta11 NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int. J. Cancer 116: 87 - 93.
31. Motsinger, A., Azimzadeh, A., Stanic, A.K., Johnson, R.P., Van Kaer, L., Joyce, S.,and, Unutmaz, D., 2003. Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells. J. Virol. 77: 8153 - 8158.
32. Porcelli, S., Yockey, C.E., Brenner, M.B.,and, Balk, S.P., 1993. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J. Exp. Med. 178: 1 - 16.
33. Rout, N., Else, J.G., Yue, S., Connole, M., Exley, M.A.,and, Kaur, A., 2010. Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection. PLoS One 5: e9787
34. Sandberg, J.K., Bhardwaj, N., and, Nixon, D.F, 2003. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur. J. Immunol. 33: 588 - 596.
35. Song, L., Asgharzadeh, S., Salo, J., Engell, K., Wu, H.W., Sposto, R., Ara, T., Silverman, A.M., DeClerck, Y.A., Seeger, R.C., and, Metelitsa, L.S, 2009. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J. Clin. Invest. 119: 1524 - 1536.
36. Spada, F.M., Koezuka, Y., and, Porcelli, S.A., 1998. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188: 1529 - 1534.
37. Tahir, S.M., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G.J., Wilson, S.B., Balk, S.P., and, Exley, M.A., 2001. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J. Immunol. 167: 4046 - 4050.
38. Thomas, S.Y., Hou, R., Boyson, J.E., Means, T.K., Hess, C., Olson, D.P., Strominger, J.L., Brenner, M.B., Gumperz, J.E., Wilson, S.B., and, Luster, A.D, 2003. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171: 2571 - 2580.
39. van der Vliet, H.J., Nishi, N., Koezuka, Y., von Blomberg, B.M., van den Eertwegh, A.J., Porcelli, S.A., Pinedo, H.M., Scheper, R.J., and, Giaccone, G., 2001. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J. Immunol. Methods 247: 61 - 72.
40. van der Vliet, H.J., Molling, J.W., Nishi, N., Masterson, A.J., Kolgen, W., Porcelli, S.A., van den Eertwegh, A.J., von Blomberg, B.M., Pinedo, H.M., Giaccone, G., and, Scheper, R.J, 2003. Polarization of Valpha24 Vbeta11 natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells. Cancer Res. 63: 4101 - 4106.
41. Wilson, S.B., Kent, S.C., Patton, K.T., Orban, T., Jackson, R.A., Exley, M., Porcelli, S., Schatz, D.A., Atkinson, M.A., Balk, S.P., Strominger, J.L., and, Hafler, D.A., 1998. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391: 177 - 181.